RxDoctor Payments Data

Scott Barnacle, MD

Obstetrics & Gynecology · Minneapolis, MNNPI 1457346926

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,000 of the $17,205 with a category attached, or 87.2%. Applied Medical Resources Corporation accounts for 93.1% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2023 at $10,277 and has fallen 99.4% since, to $62 in 2025. Among obstetrics & gynecology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,205in general payments, 2019–2025

Across 76 payments — averaging $226.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$16K
  • Hologic Sales And Service, LLC$149
  • Bayer$117
  • Avanos Medical$100
  • Daiichi Sankyo Inc.$88
  • Exact Sciences$71
  • plus $653 from 19 others

What the payments were for

  • Speaking & faculty fees$15,00087%
  • Travel & lodging$6514%
  • Food & beverage$1,5549%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,205 in reported general payments places this provider in the 95th percentile of 615 obstetrics & gynecology providers in Minnesota.

See all obstetrics & gynecology providers in Minnesota

Medicare billing

Part B allowed, 2024
$31,049
Medicare patients
71
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol40$1,681
Solifenacin Succinate22$1,090
Oxybutynin Chloride ErOxybutynin Chloride20$262
Medroxyprogesterone Acetate28$261
Norethindrone11$188
Norethindrone Acetate12$162

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →